Related Experiment Videos
[Recent advances in inborn errors of metabolism]
1Departamento de Neurologia da Faculdade de Medicina, Universidade de São Paulo.
Arquivos De Neuro-Psiquiatria
|June 1, 1987
Summary
Advances in inborn errors of metabolism (IEM) cover pathogenesis, diagnostics, and therapeutics. New IEM variants and treatment outcomes, including mucopolysaccharidosis, are presented.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Context:
- Inborn errors of metabolism (IEM) represent a complex group of genetic disorders.
- Understanding IEM pathogenesis, genetic heterogeneity, and clinical variability is crucial.
Purpose:
- To review recent advances in the comprehension, diagnosis, and treatment of inborn errors of metabolism.
- To present novel IEM variants and diagnostic methodologies.
- To report initial therapeutic outcomes for mucopolysaccharidosis.
Summary:
- Analysis of IEM pathogenesis, genetic localization, and heterogeneity.
- Description of new IEM variants and clinical presentations.
- Overview of current laboratory diagnostic tests, including genetic marker assays, newborn screening, heterozygote detection, and prenatal diagnosis.
- Discussion of therapeutic strategies, including special diets, plasmapheresis, and leukapheresis, with preliminary results for mucopolysaccharidosis cases.
Impact:
- Enhanced understanding of IEM pathophysiology and genetic basis.
- Improved diagnostic capabilities for IEM detection and characterization.
- Insights into novel therapeutic approaches and their efficacy in managing IEM, particularly mucopolysaccharidosis.